Michael R Hayden Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Michael R Hayden is Director of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 116,206 shares of XENE, which is worth approximately $4.57 Million. The most recent transaction as insider was on May 18, 2021, when has been sold 3,500 shares (Common Shares) at a price of $3.85 per share, resulting in proceeds of $13,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
0% 3M change
0% 12M change
Total Value Held $4.57 Million

Michael R Hayden Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2021
BUY
Exercise of conversion of derivative security
$13,475 $3.85 p/Share
3,500 Added 2.92%
116,206 Common Shares
Feb 16 2021
BUY
Exercise of conversion of derivative security
$13,786 $2.68 p/Share
5,144 Added 4.36%
112,706 Common Shares

Also insider at

IONS
IONIS PHARMACEUTICALS INC Healthcare
Director
ABCL
AbCellera Biologics Inc. Healthcare
Director
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
ETNB
89bio, Inc. Healthcare
MRH

Michael R Hayden

Director
Carlsbad, CA

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE